Clinical Trials Browser

Phase 1/2 × Gefitinib × Dermatologic × Clear all

NCT00423397 2013-12-19

Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer

Phase 1/2 Unknown

Skin Neoplasms